Brief: Aequus Extends Commercial Agreement For Specialty Product Tacrolimus IR In Canada
16/10/2020 13:08
Oct 16 (Reuters) - Aequus Pharmaceuticals Inc AQS.V :
* AEQUUS EXTENDS COMMERCIAL AGREEMENT FOR SPECIALTY PRODUCT
TACROLIMUS IR IN CANADA
Source text for Eikon: ID:nGNXcfTDTy
Further company coverage: AQS.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aequus Pharmaceuticals
See all newsBrief: Aequus Pharmaceutical Canada Pauses Sales Of Evolve Intensive Eyedrops, Gel In Canada
Brief: Aequus Announces Financing To Support Launch Of Zimed Preservative Free (Bimatoprost 0.03%) And Board Update
Brief: Aequus Announces Health Canada Notice Of Compliance For Zimed® Preservative Free
Brief: Aequus Announces Sandoz Contract Expiry At Year End And Expected Health Canada Approval For Zimed® Pf (Preservative Free)
Brief: Aequus Resumes Trading On TSX Venture Exchange